Get our Free Patent Expiration Newsletter

Serving hundreds of leading biopharmaceutical companies globally:

Deloitte
Queensland Health
Cipla
Chinese Patent Office
Teva
Chubb

Generated: July 22, 2019

DrugPatentWatch Database Preview

Patent: 9,492,506

Try a free trialSee Plans and Pricing

« Back to Dashboard

Summary for Patent: 9,492,506
Title:Oligonucleotide chelate complex--polypeptide compositions and methods
Abstract: It is disclosed a pharmaceutical composition containing an oligonuclelotide chelate complex and at least one polypeptide or pegylated polypeptide. The present disclosure also describes additional pharmaceutical compositions and methods for the treatment of diseases including viral infections.
Inventor(s): Bazinet; Michel (Montreal, CA), Vaillant; Andrew (Roxboro, CA)
Assignee: REPLICOR INC. (Montreal, CA)
Application Number:13/896,510
Patent Claims:see list of patent claims

Details for Patent 9,492,506

Applicant Tradename Biologic Ingredient Dosage Form BLA Number Approval Date Patent No. Assignee Patent Expiration Status Orphan Source
Vidara Therapeutics Research Ltd ACTIMMUNE interferon gamma-1b VIAL; SINGLE-USE 103836 001 1999-02-25 ➤ Try a Free Trial REPLICOR INC. (Montreal, CA) ➤ Try a Free Trial RX search
Serono Inc REBIF interferon beta-1a SYRINGE 103780 002 2002-03-07 ➤ Try a Free Trial REPLICOR INC. (Montreal, CA) ➤ Try a Free Trial RX search
Serono Inc REBIF interferon beta-1a SYRINGE 103780 001 2002-03-07 ➤ Try a Free Trial REPLICOR INC. (Montreal, CA) ➤ Try a Free Trial RX search
Biogen AVONEX interferon beta-1a VIAL 103628 001 1996-05-17 ➤ Try a Free Trial REPLICOR INC. (Montreal, CA) ➤ Try a Free Trial RX search
Applicant Tradename Biologic Ingredient Dosage Form BLA Number Approval Date Patent No. Assignee Patent Expiration Status Orphan Source

Subscribe to access the full database, or try a Free Trial

Make Better Decisions: Try a trial or see plans & pricing

Serving hundreds of leading biopharmaceutical companies globally:

Baxter
Daiichi Sankyo
AstraZeneca
US Army
Express Scripts
Julphar

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.